REFERENCES

2.

Andersen

N

,

Hjortdal

,

JØ

,

Schielke

KC

, et al.

The Danish Registry of Diabetic Retinopathy

.

Clin Epidemiol

2016

;

8

:

613

–

619

3.

Scanlon

PH

.

The English National Screening Programme for diabetic retinopathy 2003–2016

.

Acta Diabetol

2017

;

54

:

515

–

525

4.

Antonetti

DA

,

Klein

R

,

Gardner

TW

.

Diabetic retinopathy

.

N Engl J Med

2012

;

366

:

1227

–

1239

5.

American Diabetes Association

.

Economic costs of diabetes in the U.S. in 2017

.

Diabetes Care

2018

;

41

:

917

–

928

6.

DCCT/EDIC Research Group

,

Aiello

LP

,

Sun

W

,

Das

A

, et al.

Intensive diabetes therapy and ocular surgery in type 1 diabetes

.

N Engl J Med

2015

;

372

:

1722

–

1733

7.

Diabetes Prevention Program Research Group

.

The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program

.

Diabet Med

2007

;

24

:

137

–

144

8.

Girach

A

,

Vignati

L

.

Diabetic microvascular complications: can the presence of one predict the development of another?

J Diabetes Complications

2006

;

20

:

228

–

237

9.

Cheung

N

,

Rogers

S

,

Couper

DJ

,

Klein

R

,

Sharrett

AR

,

Wong

TY

.

Is diabetic retinopathy an independent risk factor for ischemic stroke?

Stroke

2007

;

38

:

398

–

401

10.

Xie

J

,

Ikram

MK

,

Cotch

MF

, et al.

Association of diabetic macular edema and proliferative diabetic retinopathy with cardiovascular disease: a systematic review and meta-analysis

.

JAMA Ophthalmol

2017

;

135

:

586

–

593

11.

Jeng

CJ

,

Hsieh

YT

,

Yang

CM

,

Yang

CH

,

Lin

CL

,

Wang

IJ

.

Development of diabetic retinopathy after cataract surgery

.

PLoS One

2018

;

13

:

e0202347

12.

Stem

MS

,

Hussain

M

,

Lentz

SI

, et al.

Differential reduction in corneal nerve fiber length in patients with type 1 or type 2 diabetes mellitus

.

J Diabetes Complications

2014

;

28

:

658

–

661

13.

Petropoulos

IN

,

Green

P

,

Chan

AW

, et al.

Corneal confocal microscopy detects neuropathy in patients with type 1 diabetes without retinopathy or microalbuminuria

.

PLoS One

2015

;

10

:

e0123517

14.

Fang

C

,

Leavitt

JA

,

Hodge

DO

,

Holmes

JM

,

Mohney

BG

,

Chen

JJ

.

Incidence and etiologies of acquired third nerve palsy using a population- based method

.

JAMA Ophthalmol

2017

;

135

:

23

–

28

15.

Shah

AR

,

Van Horn

AN

,

Verchinina

L

, et al.

Blood pressure is associated with receiving intravitreal anti-vascular endothelial growth factor treatment in patients with diabetes. Ophthalmol Retina

.

Epub ahead of print on 2 February 2019. (doi: 10.1016/j.oret.2019.01.019)

16.

Zhang

L

,

Krzentowski

G

,

Albert

A

,

Lefebvre

PJ

.

Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control

.

Diabetes Care

2001

;

24

:

1275

–

1279

17.

Chew

EY

,

Davis

MD

,

Danis

RP

, et al.;

Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study

.

Ophthalmology

2014

;

121

:

2443

–

2451

18.

U.K. Prospective Diabetes Study Group

.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

.

Lancet

1998

;

352

:

837

–

853

19.

DCCT Research Group

.

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus

.

N Engl J Med

1993

;

329

:

977

–

986

20.

Duckworth

W

,

Abraira

C

,

Moritz

T

, et al.;

VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes

.

N Engl J Med

2009

;

360

:

129

–

139

21.

Wong

TY

,

Cheung

CM

,

Larsen

M

,

Sharma

S

,

Simó

R

.

Diabetic retinopathy

.

Nat Rev Dis Primers

2016

;

2

:

16012

22.

DCCT/EDIC Research Group

;

Lachin

JM

,

Genuth

S

,

Cleary

P

,

Davis

MD

,

Nathan

DM

.

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

.

N Engl J Med

2000

;

342

:

381

–

389

23.

ACCORDION Eye Study Group and ACCORDION Study Group

.

Persistent effects of intensive glycemic control on retinopathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study

.

Diabetes Care

2016

;

39

:

1089

–

1100

24.

Holman

RR

,

Paul

SK

,

Bethel

MA

,

Matthews

DR

,

Neil

HA

.

10-year follow-up of intensive glucose control in type 2 diabetes

.

N Engl J Med

2008

;

359

:

1577

–

1589

25.

American Diabetes Association

.

6. Glycemic targets: Standards of Medical Care in Diabetes—2019

.

Diabetes Care

2019

;

42

(

Suppl. 1

):

S61

–

S70

26.

Bain

SC

,

Klufas

MA

,

Ho

A

,

Matthews

DR

.

Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review

.

Diabetes Obes Metab

2019

;

21

:

454

–

466

27.

Feldman-Billard

S

,

Larger

É

,

Massin

P

;

Standards for Screening and Surveillabce of Ocular Complications in People with Diabetes SFD Study Group. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes

.

Diabetes Metab

2018

;

44

:

4

–

14

28.

DCCT Research Group

.

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial

.

Arch Ophthalmol

1998

;

116

:

874

–

886

29.

Aiello

LP

,

for the DCCT/EDIC Research Group

.

Diabetic retinopathy and other ocular findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

.

Diabetes Care

2014

;

37

:

17

–

23

30.

Early Treatment Diabetic Retinopathy Study Research Group

.

Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10

.

Ophthalmology

1991

;

98

(

Suppl. 5

):

786

–

806

31.

Li

Y

,

Ryu

C

,

Munie

M

, et al.

Association of metformin treatment with reduced severity of diabetic retinopathy in type 2 diabetic patients

.

J Diabetes Res

2018

;

2018

:

2801450

32.

Oshitari

T

,

Asaumi

N

,

Watanabe

M

,

Kumagai

K

,

Mitamura

Y

.

Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study

.

Vasc Health Risk Manag

2008

;

4

:

1137

–

1140

33.

Dicembrini

I

,

Nreu

B

,

Scatena

A

, et al.

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta- analysis of randomized controlled trials

.

Acta Diabetol

2017

;

54

:

933

–

941

34.

Dorsey-Treviño

EG

,

Contreras-Garza

BM

,

González-González

JG

, et al.

Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol

.

BMJ Open

2018

;

8

:

e020692

35.

Mieno

H

,

Yoneda

K

,

Yamazaki

M

,

Sakai

R

,

Sotozono

C

,

Fukui

M

.

The efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of chronic diabetic macular oedema in vitrectomised eyes: a retrospective study

.

BMJ Open Ophthalmol

2018

;

3

:

e000130

36.

Idris

I

,

Warren

G

,

Donnelly

R

.

Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes

.

Arch Intern Med

2012

;

172

:

1005

–

1011

37.

Gower

EW

,

Lovato

JF

,

Ambrosius

WT

, et al.;

ACCORD Study Group

.

Lack of longitudinal association between thiazolidinediones and incidence and progression of diabetic eye disease: the ACCORD Eye Study

.

Am J Ophthalmol

2018

;

187

:

138

–

147

38.

Schrier

RW

,

Estacio

RO

,

Esler

A

,

Mehler

P

.

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

.

Kidney Int

2002

;

61

:

1086

–

1097

39.

U.K. Prospective Diabetes Study Group

.

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

.

BMJ

1998

;

317

:

703

–

713

40.

Giusti

C

,

Forte

R

,

Vingolo

EM

,

Gargiulo

P

.

Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study

.

Int Ophthalmol

2001

;

24

:

79

–

88

41.

Estacio

RO

,

McFarling

E

,

Biggerstaff

S

,

Jeffers

BW

,

Johnson

D

,

Schrier

RW

.

Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM

.

Am J Kidney Dis

1998

;

31

:

947

–

953

42.

Chung

YR

,

Park

SW

,

Choi

SY

, et al.

Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy

.

Cardiovasc Diabetol

2017

;

16

:

4

43.

Knickelbein

JE

,

Abbott

AB

,

Chew

EY

.

Fenofibrate and diabetic retinopathy

.

Curr Diab Rep

2016

;

16

:

90

44.

Hwang

H

,

Chae

JB

,

Kim

JY

,

Moon

BG

,

Kim

DY

.

Changes in optical coherence tomography findings in patients with chronic renal failure undergoing dialysis for the first time. Retina

.

Epub ahead of print on 30 August 2018 (doi: 10.1097/IAE.0000000000002312)

45.

Ong

SS

,

Thomas

AS

,

Fekrat

S

.

Improvement of recalcitrant diabetic macular edema after peritoneal dialysis

.

Ophthalmic Surg Lasers Imaging Retina

2017

;

48

:

834

–

837

46.

Theodossiadis

PG

,

Theodoropoulou

S

,

Neamonitou

G

, et al.

Hemodialysis-induced alterations in macular thickness measured by optical coherence tomography in diabetic patients with end-stage renal disease

.

Ophthalmologica

2012

;

227

:

90

–

94

47.

Ciardella

AP

.

Partial resolution of diabetic macular oedema after systemic treatment with furosemide

.

Br J Ophthalmol

2004

;

88

:

1224

–

1225

48.

American Diabetes Association

.

4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Medical Care in Diabetes—2019

.

Diabetes Care

2019

;

42

(

Suppl. 1

):

S34

–

S45

49.

Gorman

DM

,

le Roux

CW

,

Docherty

NG

.

The effect of bariatric surgery on diabetic retinopathy: good, bad, or both?

Diabetes Metab J

2016

;

40

:

354

–

364

50.

Richardson

P

,

Hulpus

A

,

Idris

I

.

Short-term impact of bariatric surgery on best-corrected distance visual acuity and diabetic retinopathy progression

.

Obes Surg

2018

;

28

:

3711

–

3713

51.

Praidou

A

,

Harris

M

,

Niakas

D

,

Labiris

G

.

Physical activity and its correlation to diabetic retinopathy

.

J Diabetes Complications

2017

;

31

:

456

–

461

52.

Loprinzi

PD

,

Edwards

MK

,

Frith

E

.

Review of the literature examining the association between physical activity and retinopathy

.

Phys Sportsmed

2018

;

46

:

123

–

128

53.

Kassoff

A

,

Catalano

RA

,

Mehu

M

.

Vitreous hemorrhage and the Valsalva maneuver in proliferative diabetic retinopathy

.

Retina

1988

;

8

:

174

–

176

54.

Androudi

S

,

Ahmed

M

,

Brazitikos

P

,

Foster

CS

.

Valsalva retinopathy: diagnostic challenges in a patient with pars-planitis

.

Acta Ophthalmol Scand

2005

;

83

:

256

–

257

55.

Tan

NYQ

,

Chew

M

,

Tham

YC

, et al.

Associations between sleep duration, sleep quality and diabetic retinopathy

.

PLoS One

2018

;

13

:

e0196399

56.

Altaf

QA

,

Dodson

P

,

Ali

A

, et al.

Obstructive sleep apnea and retinopathy in patients with type 2 diabetes: a longitudinal study

.

Am J Respir Crit Care Med

2017

;

196

:

892

–

900

57.

Cai

X

,

Chen

Y

,

Yang

W

,

Gao

X

,

Han

X

,

Ji

L

.

The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis

.

Endocrine

2018

;

62

:

299

–

306

58.

Martin-Merino

E

,

Fortuny

J

,

Rivero-Ferrer

E

,

Lind

M

,

Garcia- Rodriguez

LA

.

Risk factors for diabetic macular oedema in type 2 diabetes: a case-control study in a United Kingdom primary care setting

.

Prim Care Diabetes

2017

;

11

:

288

–

296

59.

Bergerhoff

K

,

Clar

C

,

Richter

B

.

Aspirin in diabetic retinopathy: a systematic review

.

Endocrinol Metab Clin North Am

2002

;

31

:

779

–

793

60.

Shi

Y

,

Tham

YC

,

Cheung

N

, et al.

Is aspirin associated with diabetic retinopathy? The Singapore Epidemiology of Eye Disease (SEED) study

.

PLoS One

2017

;

12

:

e0175966

61.

DCCT Research Group

.

Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial

.

Diabetes Care

2000

;

23

:

1084

–

1091

62.

Axer-Siegel

R

,

Hod

M

,

Fink-Cohen

S

, et al.

Diabetic retinopathy during pregnancy

.

Ophthalmology

1996

;

103

:

1815

–

1819

63.

Chew

EY

,

Mills

JL

,

Metzger

BE

, et al.

Metabolic control and progression of retinopathy: the Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study

.

Diabetes Care

1995

;

18

:

631

–

637

64.

American Diabetes Association

.

11. Microvascular complications and foot care: Standards of Medical Care in Diabetes—2019

.

Diabetes Care

2019

;

42

(

Suppl. 1

):

S124

–

S138

65.

Tang

J

,

Li

T

,

Li

P

, et al.

Early assessment of the risk factors for diabetic retinopathy can reduce the risk of peripheral arterial and cardiovascular diseases in type 2 diabetes

.

Ophthalmic Res

2018

;

59

:

221

–

227

66.

Scott

A

,

Bressler

N

,

Ffolkes

S

,

Wittenborn

JS

,

Jorkasky

J

.

Public attitudes about eye and vision health

.

JAMA Ophthalmol

2016

;

134

:

1111

–

1118

67.

National Institute of Diabetes and Digestive and Kidney Disease

.

Diabetes statistics

.

Available from www.niddk.nih.gov/health-information/health-statistics/diabetes-statistics. Accessed 31 January 2019

68.

National Eye Institute

.

Cataracts. Available from nei.nih.gov/eyedata/cataract. Accessed 31 January 2019

69.

Michael

R

,

Bron

AJ

.

The ageing lens and cataract: a model of normal and pathological ageing

.

Philos Trans R Soc Lond B Biol Sci

2011

;

366

:

1278

–

1292

70.

Javadi

M

,

Zarei-Ghanavati

S

.

Cataracts in diabetic patients: a review article

.

J Ophthalmic Vis Res

2008

;

3

:

52

–

65

71.

Kinoshita

JH

,

Fukushi

S

,

Kador

P

,

Merola

LO

.

Aldose reductase in diabetic complications of the eye

.

Metabolism

1979

;

28

(

Suppl. 1

)

462

–

469

72.

Becker

C

,

Schneider

C

,

Aballéa

S

, et al.

Cataract in patients with diabetes mellitus: incidence rates in the UK and risk factors

.

Eye (Lond)

2018

;

32

:

1028

–

1035

73.

Lindstrom

R

Thoughts on cataract surgery: 2015. Review of Ophthalmology 9 March 2015

.

Available from www.reviewofophthalmology.com/article/thoughts-on--cataract-surgery-2015. Accessed 24 January 2019

74.

Davis

G

The evolution of cataract surgery

.

Mo Med

2016

;

113

:

58

–

62

75.

Steinle

NC

,

Lampen

SIR

,

Wykoff

CC

.

Editorial: the intersection of diabetes mellitus and cataract surgery: current state of management

.

Ophthalmol Retina

2018

;

2

:

83

–

85

76.

Wu

S

,

Tong

N

,

Pan

L

, et al.

Retrospective analyses of potential risk factors for posterior capsule opacification after cataract surgery

.

J Ophthalmol

2018

;

2018

:

9089285

77.

Herrinton

LJ

,

Shorstein

NH

,

Paschal

JF

, et al.

Comparative effectiveness of antibiotic prophylaxis in cataract surgery

.

Ophthalmology

2016

;

123

:

287

–

294

78.

Sohn

EH

,

van Dijk

HW

,

Jiao

C

, et al.

Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus

.

Proc Natl Acad Sci U S A

2016

;

113

:

E2655

–

E2664

79.

Gardner

TW

,

Davila

JR

.

The neurovascular unit and the pathophysiologic basis of diabetic retinopathy

.

Graefes Arch Clin Exp Ophthalmol

2017

;

255

:

1

–

6

80.

van Dijk

HW

,

Verbraak

FD

,

Kok

PH

, et al.

Early neurodegeneration in the retina of type 2 diabetic patients

.

Invest Ophthalmol Vis Sci

2012

;

53

:

2715

–

2719

81.

Sun

JK

,

Radwan

SH

,

Soliman

AZ

, et al.

Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema

.

Diabetes

2015

;

64

:

2560

–

2570

82.

Fante

RJ

,

Gardner

TW

,

Sundstrom

JM

.

Current and future management of diabetic retinopathy: a personalized evidence-based approach

.

Diabetes Manag

2013

;

3

:

481

–

494

83.

Klein

R

,

Knudtson

MD

,

Lee

KE

,

Gangnon

R

,

Klein

BE

.

The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes

.

Ophthalmology

2009

;

116

:

497

–

503

84.

Kotoula

MG

,

Koukoulis

GN

,

Zintzaras

E

,

Karabatsas

CH

, and

Chatzoulis

DZ

.

Metabolic control of diabetes is associated with an improved response of diabetic retinopathy to panretinal photocoagulation

.

Diabetes Care

2005

;

28

:

2454

–

2457

85.

Early Treatment Diabetic Retinopathy Study Research Group

.

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1

.

Arch Ophthalmol

1985

;

103

:

1796

-

1806

86.

Brown

DM

,

Nguyen

QD

,

Marcus

DM

, et al.;

RIDE

and

RISE Research Group

.

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE

.

Ophthalmology

2013

;

120

:

2013

–

2022

87.

Heier

JS

,

Korobelnik

JF

,

Brown

DM

, et al.

Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies

.

Ophthalmology

2016

;

123

:

2376

–

2385

88.

Diabetic Retinopathy Clinical Research Network

,

Wells

JA

,

Glassman

AR

,

Ayala

AR

, et al.

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema

.

N Engl J Med

2015

;

372

:

1193

–

1203

89.

Boyer

DS

,

Yoon

YH

,

Belfort

R

Jr, et al.;

Ozurdex MEAD Study Group

.

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema

.

Ophthalmology

2014

;

121

:

1904

–

1914

90.

Campochiaro

PA

,

Brown

DM

,

Pearson

A

, et al.;

FAME Study Group

.

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema

.

Ophthalmology

2012

;

119

:

2125

–

2132

91.

Writing Committee for the UK Age-Related Macular Degeneration EMR User Group

.

The neovascular age-related macular degeneration database: multicenter study of 92,976 ranibizumab injections: report 1: visual acuity

.

Ophthalmology

2014

;

121

:

1092

–

1101

92.

Ho

AC

,

Albini

TA

,

Brown

DM

,

Boyer

DS

,

Regillo

CD

,

Heier

JS

.

The potential importance of detection of neovascular age-related macular degeneration when visual acuity is relatively good

.

JAMA Ophthalmol

2017

;

135

:

268

–

273

93.

Nguyen

QD

,

Brown

DM

,

Marcus

DM

, et al.;

RISE and RIDE Research Group. Ranibizumab for diabetic mecular edema: results from 2 phase III randomized trials: RISE and RIDE

.

Ophthalmology

2012

;

119

:

789

–

801

94.

Korobelnik

JF

,

Do

DV

,

Schmidt-Erfurth

U

, et al.

Intravitreal aflibercept for diabetic macular edema

.

Ophthalmology

2014

;

121

:

2247

–

2254

95.

Wells

JA

,

Glassman

AR

,

Ayala

AR

, et al.;

Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial

.

Ophthalmology

2016

;

123

:

1351

–

1359

96.

Bressler

NM

,

Beaulieu

WT

,

Glassman

AR

, et al.;

Diabetic Retinopathy Clinical Research Network. Persistent macular thickening following intravitreous aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision impairment: a secondary analysis of a randomized clinical trial

.

JAMA Ophthalmol

2018

;

136

:

257

–

269

97.

Maturi

RK

,

Glassman

AR

,

Liu

D

, et al.;

Diabetic Retinopathy Clinical Research Network. Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: a DRCR Network phase 2 randomized clinical trial

.

JAMA Ophthalmol

2018

;

136

:

29

–

38

98.

Boyer

DS

,

Nguyen

QD

,

Brown

DM

,

Basu

K

,

Ehrlich

JS

;

RIDE

and

RISE Research Group

.

Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials

.

Ophthalmology

2015

;

122

:

2504

–

2513

99.

Wykoff

CC

,

Ou

WC

,

Khurana

RN

,

Brown

DM

,

Lloyd Clark

W

,

Boyer

DS

;

ENDURANCE Study Group

.

Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study

.

Br J Ophthalmol

2018

;

102

:

631

–

636

100.

Diabetic Retinopathy Study Research Group

.

Preliminary report on effects of photocoagulation therapy

.

Am J Ophthalmol

1976

;

81

:

383

–

396

101.

Gross

JG

,

Glassman

AR

,

Liu

D

, et al.;

Diabetic Retinopathy Clinical Research Network. Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial

.

JAMA Ophthalmol

2018

;

136

:

1138

–

1148

102.

Ip MS, Domalpally A, Hopkins JJ,Wong P, Ehrlich JS. Long-term effects of ranibizumab on diabetic retinopathy severity and progression

.

Arch Ophthalmol

2012

;

130

:

1145

–

1152

103.

Wykoff

CC

,

Chakravarthy

U

,

Campochiaro

PA

,

Bailey

C

,

Green

K

,

Cunha-Vaz

J

.

Long-term effects of intravitreal 0.19 mg fluocinolone acetonide implant on progression and regression of diabetic retinopathy

.

Ophthalmology

2017

;

124

:

440

–

449

104.

Wykoff

CC

,

Eichenbaum

DA

,

Roth

DB

,

Hill

L

,

Fung

AE

,

Haskova

Z

.

Ranibizumab induces regression of diabetic retinopathy in most patients at high risk of progression to proliferative diabetic retinopathy

.

Ophthalmol Retina

2018

;

2

:

997

–

1009

105.

Campochiaro

PA

,

Wykoff

CC

,

Shapiro

H

,

Rubio

RG

,

Ehrlich

JS

.

Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema

.

Ophthalmology

2014

;

121

:

1783

–

1789

106.

ClinicalTrials.gov. Study of the efficacy and safety of intravitreal (IVT) aflibercept for the improvement of moderately severe to severe nonproliferative diabetic retinopathy (NPDR) (PANORAMA). Available from clinicaltrials.gov/ct2/show/NCT02718326. Accessed 25 January 2019

107.

107

ClinicalTrials.gov

Anti-VEGF treatment for prevention of PDR/ DME. Available from clinicaltrials.gov/ct2/show/NCT02634333. Accessed 25 January 2019

108.

Wallick

CJ

,

Hansen

RN

,

Campbell

J

,

Kiss

S

,

Kowalski

JW

,

Silluvan

SD

.

Comorbidity and health care resource use among commercially insured non-elderly patients with diabetic macular edema

.

Ophthalmic Surg Lasers Imaging Retina

2015

;

46

:

744

–

751

109.

Holekamp

NM

,

Campbell

J

,

Almony

A

, et al.

Vision outcomes following anti-vascular endothelial growth factor treatment of diabetic macular edema in clinical practice

.

Am J Ophthalmol

2018

;

191

:

83

–

91

110.

Obeid

A

,

Gao

X

,

Ali

FS

, et al.

Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections

.

Ophthalmology

2018

;

125

:

1386

–

1392

111.

American Diabetes Association. 5. Lifestyle Management: Standards of Medical Care in Diabetes—2019

.

Diabetes Care

2019

;

42

(

Suppl. 1

):

S46

–

S60

112.

Hendrieckx

C

,

Halliday

JA

,

Beeney

LJ

,

Speight

J

.

Diabetes and Emotional Health: A Handbook for Health Professionals Supporting Adults with Type 1 or Type 2 Diabetes

.

Canberra, Australia

,

National Diabetes Services Scheme

,

2016

113.

Powers

MA

,

Bardsley

J

,

Cypress

M

, et al.

Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics

.

Diabetes Care

2015

;

38

:

1372

–

1382

114.

Ferrari

AJ

,

Somerville

AJ

,

Baxter

AJ

, et al.

Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature

.

Psychol Med

2013

;

43

:

471

–

481

115.

Nicolucci

A

,

Kovacs Burns

K

,

Holt

RI

, et al.;

DAWN2 Study Group

.

Diabetes Attitudes, Wishes and Needs Second Study (DAWN2): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes

.

Diabet Med

2013

;

30

:

767

–

777

116.

National Eye Institute

.

Health education leads to more eye exams in group at risk for vision loss

.

Available from nei.nih.gov/news/pressreleases/morexam. Accessed 29 January 2019

117.

Dickinson

JK

,

Guzman

SJ

,

Maryniuk

MD

, et al.

The use of language in diabetes care and education

.

Diabetes Care

2017

;

40

:

1790

–

1799

118.

Wardian JL. Diabetes cannot be controlled, but it can be managed

.

Clin Diabetes

2017

;

35

:

329

–

330

119.

NHS England

.

Language Matters: Language and Diabetes

.

Available from www.england.nhs.uk/wp-content/uploads/2018/06/language-matters.pdf. Access 29 January 2019

120.

Dickinson

JK

,

Maryniuk

MD

.

Building therapeutic relationships: choosing words that put people first

.

Clin Diabetes

2017

;

35

:

51

–

54

121.

Solomon

SD

,

Chew

E

,

Duh

EJ

, et al.

Diabetic retinopathy: a position statement by the American Diabetes Association

.

Diabetes Care

2017

;

40

:

412

–

418

122.

Aiello

LP

,

Gardner

TW

,

King

GL

, et al.

Diabetic retinopathy

.

Diabetes Care

1998

;

21

:

143

–

156

123.

An

J

,

Niu

F

,

Turpcu

A

,

Raiput

Y

,

Cheetham

TC

.

Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States

.

Ophthalmic Epidemiol

2018

;

25

:

257

–

265

124.

Prentki

M

,

Nolan

CJ

.

Islat beta cell failure in type 2 diabetes

.

J Clin Invest

2006

;

116

:

1802

–

1812

125.

Chen

X

,

Seth

RK

,

Rao

VS

,

Huang

JJ

,

Adelman

RA

.

Effects of music therapy on intravitreal injections: a randomized clinical trial

.

J Ocul Pharmacol Ther

2012

;

28

:

414

–

419